373 related articles for article (PubMed ID: 37835465)
1. Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis.
Zareinejad M; Mehdipour F; Roshan-Zamir M; Faghih Z; Ghaderi A
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835465
[TBL] [Abstract][Full Text] [Related]
2. Quantitative high-throughput analysis of tumor infiltrating lymphocytes in breast cancer.
Hayashi K; Nogawa D; Kobayashi M; Asakawa A; Ohata Y; Kitagawa S; Kubota K; Takahashi H; Yamada M; Oda G; Nakagawa T; Uetake H; Onishi I; Kinowaki Y; Kurata M; Kitagawa M; Yamamoto K
Front Oncol; 2022; 12():901591. PubMed ID: 36132149
[TBL] [Abstract][Full Text] [Related]
3. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
Front Immunol; 2014; 5():180. PubMed ID: 24795723
[TBL] [Abstract][Full Text] [Related]
4. Immunity and Extracellular Matrix Characteristics of Breast Cancer Subtypes Based on Identification by T Helper Cells Profiling.
Zhou Y; Tian Q; Gao H; Zhu L; Zhang Y; Zhang C; Yang J; Wang B
Front Immunol; 2022; 13():859581. PubMed ID: 35795662
[TBL] [Abstract][Full Text] [Related]
5. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
[TBL] [Abstract][Full Text] [Related]
6. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
[TBL] [Abstract][Full Text] [Related]
7. Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival.
Schlotter CM; Tietze L; Vogt U; Heinsen CV; Hahn A
Horm Mol Biol Clin Investig; 2017 Sep; 32(2):. PubMed ID: 28937963
[TBL] [Abstract][Full Text] [Related]
8. Immune microenvironment in different molecular subtypes of ductal breast carcinoma.
Sadeghalvad M; Mohammadi-Motlagh HR; Rezaei N
Breast Cancer Res Treat; 2021 Jan; 185(2):261-279. PubMed ID: 33011829
[TBL] [Abstract][Full Text] [Related]
9. Tumor infiltrating lymphocytes in early breast cancer.
Pruneri G; Vingiani A; Denkert C
Breast; 2018 Feb; 37():207-214. PubMed ID: 28363679
[TBL] [Abstract][Full Text] [Related]
10. Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.
Burugu S; Asleh-Aburaya K; Nielsen TO
Breast Cancer; 2017 Jan; 24(1):3-15. PubMed ID: 27138387
[TBL] [Abstract][Full Text] [Related]
11. Immune phenotype of patients with stage IV metastatic inflammatory breast cancer.
Fernandez SV; MacFarlane AW; Jillab M; Arisi MF; Yearley J; Annamalai L; Gong Y; Cai KQ; Alpaugh RK; Cristofanilli M; Campbell KS
Breast Cancer Res; 2020 Dec; 22(1):134. PubMed ID: 33267869
[TBL] [Abstract][Full Text] [Related]
12. In silico analysis of the immune microenvironment in bladder cancer.
Zhang Y; Ou DH; Zhuang DW; Zheng ZF; Lin ME
BMC Cancer; 2020 Mar; 20(1):265. PubMed ID: 32228629
[TBL] [Abstract][Full Text] [Related]
13. CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer.
Vahidi Y; Bagheri M; Ghaderi A; Faghih Z
BMC Cancer; 2020 Mar; 20(1):257. PubMed ID: 32228503
[TBL] [Abstract][Full Text] [Related]
14. Effect of metabolism on the immune microenvironment of breast cancer.
Zhou Y; Wang H; Luo Y; Tuo B; Liu X; Li T
Biochim Biophys Acta Rev Cancer; 2023 Mar; 1878(2):188861. PubMed ID: 36813054
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?
Whiteside TL
Cancer Immunol Immunother; 2014 Jan; 63(1):67-72. PubMed ID: 24213679
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
17. High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer.
Gatti G; Betts C; Rocha D; Nicola M; Grupe V; Ditada C; Nuñez NG; Roselli E; Araya P; Dutto J; Boffelli L; Fernández E; Coussens LM; Maccioni M
Breast Cancer Res; 2021 Mar; 23(1):40. PubMed ID: 33766090
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients.
Knebel M; Körner S; Kühn JP; Wemmert S; Brust L; Smola S; Wagner M; Bohle RM; Morris LGT; Pandey A; Schick B; Linxweiler M
Front Immunol; 2023; 14():1172768. PubMed ID: 37383237
[TBL] [Abstract][Full Text] [Related]
19. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.
Finn OJ
Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii6-9. PubMed ID: 22918931
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]